<DOC>
	<DOCNO>NCT02662504</DOCNO>
	<brief_summary>Malignant pleural mesothelioma ( MPM ) aggressive tumour poor prognosis ( median survival &lt; 13 month ) , high resistance chemotherapy . Extended pleurectomy/decortication ( eP/D ) debulking surgery MPM consider curative treatment . Therefore suggest eP/D may interest combine intra-operative treatment adjuvant therapy . Photodynamic Therapy ( PDT ) innovative treatment base rationale tumour cell , previously treat photosensitizing drug ( Photofrin ) , die expose light particular wavelength . Interestingly PDT might also stimulate anti-tumour immune response release tumour antigen induced inflammation . PDT test phase I-II trial MPM combination EPP eP/D , chemotherapy . US study J Friedberg et al find promising survival result MPM combine eP/D , EPP , intra-operative PDT chemotherapy ( cisplatin-pemetrexed ) , median overall survival 31.7 month . However , definitive value intra-pleural PDT combine eP/D treatment MPM still need validate . The multimodal treatment establish Lille , French national expert centre MPM , help american colleague . Therefore , phase II trial propose patient benefit combination eP/D , intra-operative PDT chemotherapy cisplatin-pemetrexed prophylactic radiotherapy . Primary endpoint feasibility patient full multimodal treatment MPM include intrapleural PDT without unacceptable unexpected grade III-IV toxicity . Secondary endpoint PFS , OS , ORR , quality life . If feasibility treatment would confirm France , multicentric , randomized trial compare experimental treatment v control arm ( multimodal treatment without PDT ) plan .</brief_summary>
	<brief_title>Intrapleural Photodynamic Therapy Multimodal Treatment Patients With Malignant Pleural Mesothelioma</brief_title>
	<detailed_description>phase II trial assess feasibility experimental multimodal treatment combining : - surgery MPM : extend pleurectomy/decortication ( eP/D ) - intra-operative ( intrapleural ) photodynamic therapy ( PDT ) . Briefly , patient receive porfimer sodium ( PHOTOFRIN® ) ( 2 mg/kg ) 24 hour eP/D ( IV injection 3-5 minute ) . Cutaneous light precaution institute immediately next 4 week . : - prophylactic chest radiotherapy surgical scar prevent tumor seeding ( 3 x 7 Gray ) - adjuvant standard chemotherapy ( ci ) platin 75 mg/m2 pemetrexed 500 mg/m2 6 cycle ( 1 cycle every 3 week ) , oral folic acid ( 400 μg daily ) vitamin B12 ( 1000 μg Q9W ) supplementation - follow-up</detailed_description>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<mesh_term>Dihematoporphyrin Ether</mesh_term>
	<mesh_term>Hematoporphyrin Derivative</mesh_term>
	<mesh_term>Trioxsalen</mesh_term>
	<criteria>histologicallyproved epithelioid malignant pleural mesothelioma ( MPM ) biopsy obtain eP/D surgery tumor stage : tumor extension controlateral lung , mediastinum , peritoneum myocardium ( &lt; T4 ) ; mediastinal lymph node extension : cN2 bulky N2 N3 ) , metastasis ( M0 ) Performance status WHO PS 01 patient fit surgery ( eP/D ) chemotherapy ( cisplatinpemetrexed ) , base clinical examination , complete normal biological workup , full assessment cardiac pulmonary function test . Predicted postsurgical value sufficient normal daily life : FEV1 &gt; 40 % ; presurgical DLCO &gt; 50 % predict value VO2max &gt; 15 ml/min/kg ; ( left ventricular ) cardiac function &gt; 50 % significant pulmonary artery hypertension write informed consent must obtain inclusion randomization Another histologic subtype epithelioid MPM time diagnosis Bulky N2 , N3 and/or M1 stage ( UICC/IMIG 1995 ) prior chemotherapy mesothelioma prior radiotherapy thorax , neck upper abdomen malignancy treat within 5 year , except basal cell carcinoma situ carcinoma cervix contraindication MPM surgery chemotherapy ( cisplatin pemetrexed ) : cardiac failure , pulmonary hypertension , liver kidney dysfunction ( GFR &lt; 60 ml/min ) , uncontrolled infection , previous major neurotoxicity ototoxicity , ... severe condition accord investigator pregnancy breast feed contraindication porfimer sodium ( Photofrin ) : porphyria know hypersensitivity porphyrin , severe hepatic impairment , tracheooesophageal bronchooesophageal fistula , suspect erosion major blood vessel due risk massive , potentially fatal haemorrhage A previous talc pleurodesis diagnostic thoracoscopy NOT exclusion criterion talc mediastinal pleura avoid keep away eP/D .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>mesothelioma</keyword>
	<keyword>multimodal treatment</keyword>
	<keyword>PDT</keyword>
	<keyword>pleura</keyword>
</DOC>